MedPath

Research on nasopharyngeal carcinoma with contrast-enhanced ultrasonography

Not Applicable
Recruiting
Conditions
nasopharyngeal carcinoma
Cancer - Head and neck
Registration Number
ACTRN12614000067673
Lead Sponsor
Shang-Yong Zhu
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Suspicion of NPC was based on the presence of metastatic cervical lymph nodes and/or a nasopharyngeal abnormality accompanied by nonspecific symptoms (e.g., epistaxis, nasal obstruction, hearing loss).

Exclusion Criteria

Patients were excluded if they did not successfully undergo US, MR imaging, and an endoscopic biopsy, or if a non-NPC tumor of the nasopharynx was diagnosed.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The diagnostic performance of US and MR imaging for NPC was evaluated using receiver-operating curve (ROC) analysis. [US examinations and MR imaging were performed prior to the nasopharyngeal endoscopy so that the biopsy would not affect the images of the nasopharynx.]
Secondary Outcome Measures
NameTimeMethod
The sensitivity and specificity of the two imaging methods were compared using the McNemar test. [At the time of ultrasound.]
© Copyright 2025. All Rights Reserved by MedPath